|
CDCA3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.83557679745672E-12 |
| Normal-vs-Stage2 |
3.595900E-03 |
| Normal-vs-Stage3 |
1.07709999996874E-06 |
| Normal-vs-Stage4 |
8.38990000000539E-05 |
| Stage1-vs-Stage2 |
9.408600E-01 |
| Stage1-vs-Stage3 |
1.056710E-03 |
| Stage1-vs-Stage4 |
1.994330E-02 |
| Stage2-vs-Stage3 |
3.859300E-03 |
| Stage2-vs-Stage4 |
3.016300E-02 |
| Stage3-vs-Stage4 |
3.426400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.31569996511638E-09 |
| Normal-vs-Asian |
2.099800E-02 |
| Caucasian-vs-AfricanAmerican |
6.801400E-01 |
| Caucasian-vs-Asian |
5.445200E-01 |
| AfricanAmerican-vs-Asian |
3.693000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
5.21820000543016E-08 |
| Male-vs-Female |
7.110100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.46340000006795E-07 |
| Normal-vs-Extreme_Weight |
7.60635998631187E-12 |
| Normal-vs-Obese |
1.71579994656668E-09 |
| Normal-vs-Extreme_Obese |
1.162310E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.655400E-01 |
| Normal_Weight-vs-Obese |
6.870800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.375700E-02 |
| Extreme_Weight-vs-Obese |
2.250400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.499500E-02 |
| Obese-vs-Extreme_Obese |
5.775500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.023410E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
2.06810124581125E-11 |
| Normal-vs-Age(81-100Yrs) |
5.779300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.660100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.116400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.842500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.022600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.641600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.371800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
7.97410026898149E-10 |
| Normal-VS-KIRP CIMP |
4.618700E-04 |
| Normal-VS-Unclassified PRCC |
2.218800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.969800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.683700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.851000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.720300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.393400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.588300E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79310000181232E-08 |
| Normal-vs-N1 |
4.6877000003942E-07 |
| Normal-vs-N2 |
5.888200E-02 |
| N0-vs-N1 |
4.220900E-04 |
| N0-vs-N2 |
3.299700E-02 |
| N1-vs-N2 |
6.417000E-01 |
|
|
